Tri Act 1mg/500mg/15mg Tablet SR
Marketer
Edinburgh Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Tri Act 1mg/500mg/15mg Tablet SR
Combinazione SR 1mg/500mg/15mg tablets effectively manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this medication enhances insulin efficiency, resulting in improved blood sugar regulation. Dosage and frequency should strictly adhere to your physician's instructions; always take it with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals may increase the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment is mandatory before commencing therapy. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Tri Act 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Tri Act 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Tri Act 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Tri Act 1mg/500mg/15mg Tablet SR should be taken with a meal.
Common Side effects of Tri Act 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Tri Act 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Tri Act 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. It should be taken with a meal.
How Tri Act 1mg/500mg/15mg Tablet SR works:
Tri Act 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Tri Act 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Tri Act 1mg/500mg/15mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Tri Act 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when prescribing Tri Act 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Tri Act 1mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment with this medication.
LiverCAUTION
Exercise caution when prescribing Tri Act 1mg/500mg/15mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Severe hepatic dysfunction contraindicates the use of Tri Act 1mg/500mg/15mg SR tablets. Physician consultation is advised.
What if you forget to take Tri Act 1mg/500mg/15mg Tablet SR :
Should you forget to take a Tri Act 1mg/500mg/15mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tri Act 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently